FULL-TIME
Remote
Posted Sep 16, 2026
180K–265K a year
Job Description
Director/Senior Director, Clinical Science - Two Positions
Obesity & Cardiometabolic Disease | United States
Kennedy Bond has been retained by a well-funded, clinical-stage biotechnology company developing next-generation oral therapies for obesity and cardiometabolic disease.
The company is advancing a differentiated portfolio of peptide therapeutics designed to address some of the biggest limitations of existing obesity treatments, including convenience, tolerability and long-term adherence.
As its clinical portfolio progresses, it is appointing two Director/Senior Director-level Clinical Scientists:
Position One: Mid-to-Late-Stage Development
Position Two: Early Clinical Development
These are not narrowly defined study-support positions. Each Clinical Scientist will work closely with senior clinical leadership and carry meaningful program-level responsibility, helping translate emerging data into clinical strategy and future development decisions.
Key responsibilities include:
• Leading the scientific design, execution and interpretation of clinical studies
• Contributing to protocols, amendments, clinical study reports and regulatory documents
• Reviewing and interpreting clinical data to identify emerging trends and risks
• Partnering across Clinical Operations, Biometrics, Regulatory, Safety and Translational Medicine
• Supporting internal governance, investigator meetings, advisory boards and health-authority interactions
• Managing relationships with CROs, investigators, consultants and other external partners
The ideal candidate will bring:
• An advanced scientific or healthcare degree, ideally a PhD, PharmD or equivalent
• Significant biotech or pharmaceutical clinical-development experience
• Strong clinical-trial design, execution, data-review and interpretation capabilities
• Experience operating across cross-functional development teams
• The ability to work independently and take ownership within a lean biotech environment
• Excellent scientific writing, communication and stakeholder-management skills
Experience in obesity, diabetes, endocrinology or broader cardiometabolic development would be particularly relevant. Exposure to GLP-1, amylin, incretin biology or peptide therapeutics would also be highly valuable. Candidates with strong clinical-development fundamentals from adjacent therapeutic areas will be considered.
This is an opportunity to join an ambitious organization at a pivotal stage of growth, work alongside an experienced clinical leadership team and directly influence programs addressing one of the largest and fastest-evolving areas of global healthcare.
Location: Ideally San Francisco; exceptional candidates elsewhere in the United States will be considered to work remotely
Compensation: $180,000–$265,000 base salary, depending on experience, plus bonus and equity
For a confidential discussion, please contact Maddie Blazeby: m.blazeby@kennedybond.com
Obesity & Cardiometabolic Disease | United States
Kennedy Bond has been retained by a well-funded, clinical-stage biotechnology company developing next-generation oral therapies for obesity and cardiometabolic disease.
The company is advancing a differentiated portfolio of peptide therapeutics designed to address some of the biggest limitations of existing obesity treatments, including convenience, tolerability and long-term adherence.
As its clinical portfolio progresses, it is appointing two Director/Senior Director-level Clinical Scientists:
Position One: Mid-to-Late-Stage Development
Position Two: Early Clinical Development
These are not narrowly defined study-support positions. Each Clinical Scientist will work closely with senior clinical leadership and carry meaningful program-level responsibility, helping translate emerging data into clinical strategy and future development decisions.
Key responsibilities include:
• Leading the scientific design, execution and interpretation of clinical studies
• Contributing to protocols, amendments, clinical study reports and regulatory documents
• Reviewing and interpreting clinical data to identify emerging trends and risks
• Partnering across Clinical Operations, Biometrics, Regulatory, Safety and Translational Medicine
• Supporting internal governance, investigator meetings, advisory boards and health-authority interactions
• Managing relationships with CROs, investigators, consultants and other external partners
The ideal candidate will bring:
• An advanced scientific or healthcare degree, ideally a PhD, PharmD or equivalent
• Significant biotech or pharmaceutical clinical-development experience
• Strong clinical-trial design, execution, data-review and interpretation capabilities
• Experience operating across cross-functional development teams
• The ability to work independently and take ownership within a lean biotech environment
• Excellent scientific writing, communication and stakeholder-management skills
Experience in obesity, diabetes, endocrinology or broader cardiometabolic development would be particularly relevant. Exposure to GLP-1, amylin, incretin biology or peptide therapeutics would also be highly valuable. Candidates with strong clinical-development fundamentals from adjacent therapeutic areas will be considered.
This is an opportunity to join an ambitious organization at a pivotal stage of growth, work alongside an experienced clinical leadership team and directly influence programs addressing one of the largest and fastest-evolving areas of global healthcare.
Location: Ideally San Francisco; exceptional candidates elsewhere in the United States will be considered to work remotely
Compensation: $180,000–$265,000 base salary, depending on experience, plus bonus and equity
For a confidential discussion, please contact Maddie Blazeby: m.blazeby@kennedybond.com
Apply and matching require a free OVN account. Browse listings anytime without signing in.